Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.

NCT05373355 is registered in ClinicalTrials.gov with Hangzhou Highlightll Pharmaceutical Co., Ltd as lead sponsor.

NCT NCT05373355
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05373355 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Safety and Efficacy of TLL018 in Patients With Chronic Spontaneous Urticaria.
Lead sponsor
Hangzhou Highlightll Pharmaceutical Co., Ltd
Phase
Phase 1
Overall status
Completed
Start date
May 10, 2022
Completion date
September 7, 2023
Enrollment
41 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic spontaneous urticaria